Welcome to our dedicated page for Clearfield SEC filings (Ticker: CLFD), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission (SEC) filings for Clearfield, Inc. (NASDAQ: CLFD), a Minnesota-based manufacturer of fiber optic management, protection, and delivery products for communications networks. Investors can review Clearfield’s regulatory disclosures to understand how the company reports on its operations, governance, and financial condition.
Clearfield’s filings include current reports on Form 8-K, which disclose material events such as financial results, governance changes, and significant transactions. Recent 8-K filings describe quarterly and annual earnings announcements, the divestiture of the Nestor Cables business through a share sale and purchase agreement, amendments to the company’s Amended and Restated Bylaws, and changes in the composition of the Board of Directors.
Through its 8-K disclosures, Clearfield has outlined bylaw amendments implementing proxy access, addressing universal proxy card rules, clarifying procedures for shareholder meetings, and establishing exclusive forum provisions for certain internal corporate claims and Securities Act claims. Other 8-Ks report on the appointment of new directors, planned retirements of existing directors, and the entry into definitive agreements related to business divestitures.
In addition to 8-Ks, investors typically consult annual reports on Form 10-K and quarterly reports on Form 10-Q (when available) for detailed information on Clearfield’s financial performance, risk factors, and business description. These periodic reports complement the company’s earnings press releases by providing more extensive narrative and financial statement data.
Stock Titan’s filings page is designed to surface Clearfield’s SEC submissions as they appear on EDGAR and to pair them with AI-powered summaries that explain key points in accessible language. Users can quickly identify which filings address topics such as share repurchase authorizations, strategic divestitures, bylaw changes, or governance updates, and then drill into the full documents for deeper analysis. This helps investors, analysts, and researchers navigate Clearfield’s regulatory history and understand the context behind movements in CLFD stock.
Clearfield Inc: Amendment to Schedule 13G by The Vanguard Group. The filing states that, following an internal realignment on January 12, 2026, certain Vanguard subsidiaries will report beneficial ownership separately under SEC Release No. 34-39538. The Vanguard Group reports 0 shares beneficially owned and 0% of class in Clearfield Inc as disclosed in this amendment.
Clearfield, Inc. director Carol Ann Wirsbinski reported an award of 2,544 shares of common stock. The shares were acquired at a stated price of $0.00 per share as a grant, not an open-market purchase, bringing her directly held total to 9,631 shares.
According to the filing, restrictions on this restricted stock lapse on the first business day prior to Clearfield’s 2027 Annual Meeting of Shareholders, meaning the shares will remain subject to vesting conditions until that time.
Kelly Catherine T. reported acquisition or exercise transactions in this Form 4 filing.
Clearfield, Inc. director Kelly Catherine T. received a grant of 2,544 shares of common stock at no cost. After this award, she directly holds 5,317 shares. The filing notes that restrictions on this restricted stock lapse on the first business day prior to the 2027 Annual Meeting of Shareholders.
Jones Walter Louis JR reported acquisition or exercise transactions in this Form 4 filing.
Clearfield, Inc. director Walter Louis Jones Jr. reported an equity award of 2,544 shares of common stock, received at a price of $0.0000 per share. After this grant, he directly holds 11,073 common shares.
According to the filing, restrictions on this restricted stock lapse on the first business day before the company’s 2027 Annual Meeting of Shareholders, meaning the award remains subject to holding conditions until that time.
Sarcevic Ademir reported acquisition or exercise transactions in this Form 4 filing.
Clearfield, Inc. director Ademir Sarcevic received a grant of 2,544 shares of common stock with a stated price of $0.0000 per share. Following this award, his directly owned holdings increased to 5,317 shares. Restrictions on this restricted stock lapse on the first business day prior to the 2027 Annual Meeting of Shareholders.
Clearfield, Inc. director Kathleen Skarvan reported receiving a grant of 2,544 shares of common stock on February 27, 2026 as a stock award. The shares were acquired at a stated price of $0.0000 per share, so no cash was paid for the grant.
Following this award, she directly owns 2,870 shares of Clearfield common stock. The filing notes that restrictions on this restricted stock will lapse on the first business day prior to the 2027 Annual Meeting of Shareholders, meaning the shares are subject to holding conditions until that time.
ROTH RONALD G reported acquisition or exercise transactions in this Form 4 filing.
Clearfield, Inc. director and 10% owner Ronald G. Roth reported an award of 2,544 shares of common stock on February 27, 2026, at a stated price of $0.00 per share. These shares are restricted stock, with restrictions scheduled to lapse on the first business day prior to the 2027 Annual Meeting of Shareholders.
After this grant, Roth directly owns 1,281,808 common shares. In addition, 176,760 common shares are held indirectly through his spouse, as disclosed in the filing.
Clearfield, Inc. director Rebecca Seidel reported an award of 2,544 shares of common stock. These shares were acquired as a grant at a price of $0.00 per share, increasing her directly held stake to 2,870 shares of common stock.
The award consists of restricted stock, meaning it is subject to vesting conditions. According to the terms, the restrictions on this restricted stock will lapse on the first business day prior to the company’s 2027 Annual Meeting of Shareholders, after which the shares will be fully vested.
Clearfield, Inc. reported the results of its 2026 Annual Meeting of Shareholders. Of 13,846,718 common shares outstanding and entitled to vote, 10,106,442 shares, or 72.98%, were represented at the meeting. Shareholders elected all eight director nominees, each receiving more than 8.18 million votes in favor, with broker non-votes of 1,644,382 on each director. Shareholders also approved, on an advisory basis, the compensation of the company’s named executive officers by a wide margin, with 8,282,235 votes for and 158,594 against. In addition, shareholders ratified and confirmed the appointment of Deloitte & Touche LLP as independent registered public accounting firm for the fiscal year ending September 30, 2026, with 10,049,089 votes for, 48,105 against, and 9,248 abstentions.
Clearfield, Inc. director Donald R. Hayward reported an open-market sale of company stock. On February 19, 2026, he sold 3,595 shares of Clearfield common stock at a weighted average price of about $32.00 per share, with individual trade prices ranging from $32.00 to $32.06. After this transaction, he directly holds 10,870 shares of Clearfield common stock.